CORONAVIRUS NEWS
SARS-CoV-2 coronavirus and COVID-19 disease: a pandemic story update
Pathology services continue to face challenges to detect the SARS-CoV-2 coronavirus, and provide laboratory support to COVID-19 disease patients.
Two years since the launch of the first SARS-CoV-2 PCR test
In the two years since it launched the world's first commercially available COVID-19 PCR test, Roche Diagnostics UK and Ireland has distributed 10 million tests from its base in West Sussex.
LumiraDx receives UK MHRA approval for SARS-CoV-2 RNA STAR Complete
LumiraDx has announced that its COVID-19 molecular assay, LumiraDx SARS-CoV-2 RNA STAR Complete, has been validated by Coronavirus Test Device Approvals (CTDA) and received UK Medicines and Healthcare products Regulatory Agency (MHRA) approval.
Introducing Omicron-reactive antibodies
The Omicron variant of the SARS-CoV-2 virus possesses multiple mutations in the spike protein. However, this variant also has mutations in the nucleocapsid protein (N).
Introducing a new disruptive T-cell test
As the SARS-CoV-2 pandemic continues to cause concerns, with new variants spreading worldwide, it is now widely recognised that there must be a move beyond a ‘test & trace’ only approach.
Measuring neutralising antibodies against SARS-CoV-2 virus
Bio-Rad Laboratories has launched Bio-Plex Pro Human SARS-CoV-2 Variant neutralisation antibody assays, which allow scientists to measure neutralising antibodies quickly and efficiently against wild-type and significant variants of SARS-CoV-2 virus.
Support for Public Health Wales in the fight against SARS-CoV-2
Public Health Wales uses Seegene’s Allplex SARS-CoV-2/Flu A/Flu B/RSV Assay and Allplex SARS-CoV-2 Variant Assay to help with the nation’s fight against SARS-CoV-2.
A statement on the new Omicron variant of SARS-CoV-2 (B.1.1.529)
Geoff Twist, Managing Director, Roche Diagnostics UK and Ireland has issued a statement on the new Omicron variant.
Moves to safeguard consumer interests around PCR testing welcomed
Randox has responded to a recent announcement on PCR testing by the Consumer and Markets Authority (CMA).
High-multiplex PCR assay capable of detecting Omicron variant
Seegene, South Korea's leading molecular diagnostics company, has confirmed that its Allplex SARS-CoV-2 Master Assay is capable of detecting Omicron's unique pattern of mutations.
Glasgow Centre for Virus Research wins Queen’s Anniversary Prize
The MRC-University of Glasgow Centre for Virus Research has been recognised with a Queen’s Anniversary Prize.
Discovering ‘Virus Velcro’: COVID-capturing face mask filter
Scientists have developed a new and affordable formulation to increase the effectiveness of face covering filters at trapping coronavirus particles, retaining up to 99.6% of the virus.
Immunoassay panels to study SARS-CoV-2 antibody response
Bio-Rad Laboratories has announced the launch of the Bio-Plex Pro Human IgA and IgM SARS-CoV-2 panels to detect IgA and IgM antibodies against four SARS-CoV-2 antigens.
Why some individuals have stronger natural defences against SARS-COV-2
A new study has revealed key insights into the natural human antiviral defences against SARS-CoV-2, the virus that causes COVID-19.
State-of-the-art PCR testing laboratory at Liverpool airport
Salutaris People, a British healthcare and testing company, has unveiled a brand new SARS-CoV-2 testing laboratory at Liverpool John Lennon Airport.
Screening for SARS-CoV-2 faster with AI than lateral-flow tests
Researchers at the University of Oxford are seeking NHSX funding for an artificial intelligence (AI) SARS-CoV-2 screening test.
App to help demystify the effect of SARS-CoV-2 mutations
The SARS-CoV-2 pandemic has focused everyone’s attention on the hidden world of viruses. The emergence of new variants, such as Beta and Delta, affects everyone: some variants spread more quickly and some are less affected by vaccines. But why?
Setting the pace for monitoring SARS-CoV-2 mutations and variants
Scientists at Children’s Hospital Los Angeles have been paying close attention to the behaviour of SARS-CoV-2 since the beginning of the pandemic, and have read the genetic sequence of the virus from every positive sample to identify mutations.
Vaccine-induce immune thrombocytopenia and thrombosis: an ELISA
Stago has developed Asserachrom HPIA-IgG, a highly sensitive and specific ELISA for detecting anti-heparin-PF4 IgG antibodies, which has recently found application in the diagnosis of VITT.
Research project to investigate support for Long Covid patients
The University of Lincoln in the UK, alongside five other British universities, will work on potentially ground-breaking research commissioned by the National Institute for Health Research (NIHR) to understand and tackle Long Covid.
Featured Supplier
Epredia was established in July 2019 through the acquisition by PHC Group of the Anatomical Pathology division of Thermo Fisher Scientific. Our name has changed, however as a standalone business our mission remains the same: to improve lives by enhancing cancer diagnostics.
We are powered by the quality brands you know and trust, such as...
Upcoming Events
analytica 2022
Messe München, Germany
June 21-24, 2022
The Genomic and Microbiology Revolution: In Technology We Trust?
Royal Air Force Museum, Hendon, London
19 July 2022
Arab Lab Live 2022
Dubai International Convention & Exhibition Centre Dubai World Trade Centre - Trade Centre - Trade Centre 2 - Dubai - United Arab Emirates
24 - 26 October 2022
Lab Innovations 2022
Hall 2 NEC, Birmingham
2 & 3 November 2022
MEDICA 2022
Messe Düsseldorf D-40474 Düsseldorf, Stockumer Kirchstraße 61
14 - 17 November 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
